Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05362344 · ClinicalTrials.gov registry record
Colorectal Cancer Screening in Cystic Fibrosis
A clinical trial of Colorectal Cancer and Cystic Fibrosis, sponsored by University of Washington, the Collaborative Health Studies Coordinating Center.
- Active
- Registry status
- 350
- Enrollment target
- 20
- Study locations
NCT05362344 is a study of Colorectal Cancer and Cystic Fibrosis that is active but no longer recruiting, run by University of Washington, the Collaborative Health Studies Coordinating Center. The registered enrollment target is 350 participants, below the 1,510-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (77% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT05362344, a study of Colorectal Cancer and Cystic Fibrosis, is active but no longer recruiting, sponsored by University of Washington, the Collaborative Health Studies Coordinating Center.
- ACTIVE NOT RECRUITING
- Registry status
- 350 participants
- Enrollment target
- 20
- Study locations
Study Summary
This multi-center study will compare multi-target DNA and quantitative FIT stool-based testing to colonoscopy in individuals with Cystic Fibrosis (CF) undergoing colon cancer screening with colonoscopy. The primary endpoint is detection of any adenomas, including advanced adenomas and colorectal cancer (CRC).
Conditions Studied
Interventions
- PROCEDURE Stool tests
Study Locations (20)
California
- University of California, Los Angeles - Los Angeles
- Stanford University Medical Center - Palo Alto
Massachusetts
- Massachusetts General Hospital - Boston
- Boston Children's Hospital - Boston
Missouri
- Saint Louis University - St Louis
- Washington University - St Louis
North Carolina
- North Carolina Children's Hospital / UNC - Chapel Hill
- Atrium Health Pulmonary Care - Charlotte
Ohio
- University Hospitals Rainbow Babies & Children's - Cleveland
- Nationwide Children's Hospital - Columbus
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Colorado
- National Jewish Health, University of Colorado - Denver
Florida
- University of Miami Hospital - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2026-06-30 |
Sponsor
University of Washington, the Collaborative Health Studies Coordinating Center5 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05362344
The ClinicalTrials.gov registry entry for NCT05362344 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,510-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (77% lower). The listed sponsor is University of Washington, the Collaborative Health Studies Coordinating Center, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Stool tests is the first listed.
NCT05362344 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Massachusetts, Missouri.
Frequently Asked Questions
What is clinical trial NCT05362344 about?
NCT05362344 is a clinical study titled "Colorectal Cancer Screening in Cystic Fibrosis". This multi-center study will compare multi-target DNA and quantitative FIT stool-based testing to colonoscopy in individuals with Cystic Fibrosis (CF) undergoing colon cancer screening with colonoscopy. The primary endpoint is detection of any adenomas, including advanced adenomas and colorectal can...
What is the current status of trial NCT05362344?
This trial is currently active not recruiting. The enrollment target is 350 participants. The study started on 2022-09-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05362344 study?
This clinical trial studies the following conditions: Colorectal Cancer, Cystic Fibrosis, Adenoma.
What interventions are being tested in trial NCT05362344?
The interventions under investigation include: Stool tests (PROCEDURE).
Who is sponsoring clinical trial NCT05362344?
This trial is sponsored by University of Washington, the Collaborative Health Studies Coordinating Center, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05362344 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Kansas, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.